ADAPTED
Alzheimer's disease apolipoprotein pathology for treatment elucidation and development
- Home
- Projects & results
- Project Factsheets
Project Factsheets
Displaying 21 projects/programmes
AETIONOMY
Organising mechanistic knowledge about neurodegenerative diseases for the improvement of drug development and therapy
AMYPAD
Amyloid imaging to prevent Alzheimer’s disease
BD4BO
Big Data for Better Outcomes
EMIF
European Medical Information Framework
EPAD
European prevention of Alzheimer’s dementia consortium
EPND
European Platform for Neurodegenerative Diseases
IM2PACT
Investigating mechanisms and models predictive of accessibility of therapeutics (IM2PACT) into the brain
IMPRiND
Inhibiting misfolded protein propagation in neurodegenerative diseases
MOPEAD
Models of patient engagement for Alzheimer’s disease
NEURONET
Efficiently networking European neurodegeneration research
PARADIGM
Patients active in research and dialogues for an improved generation of medicines: advancing meaningful patient engagement in the life cycle of medicines for better health outcomes
PHAGO
Inflammation and AD: modulating microglia function - focussing on TREM2 and CD33
Pharma-Cog
Prediction of cognitive properties of new drug candidates for neurodegenerative diseases in early clinical development
PRISM
Psychiatric Ratings using Intermediate Stratified Markers: providing quantitative biological measures to facilitate the discovery and development of new treatments for social and cognitive deficits in AD, SZ, and MD
PRISM 2
Psychiatric ratings using intermediate stratified markers 2
RADAR-AD
Remote assessment of disease and relapse – Alzheimer’s disease
ReSOLUTE
Research empowerment on solute carriers
REsolution
Add medical genetic solutions to RESOLUTE (REsolution)
ROADMAP
Real world outcomes across the AD spectrum for better care: multi-modal data access platform
STEMBANCC
Stem cells for biological assays of novel drugs and predictive toxicology
